Druglike co-founder Martin Shkreli (AP Photo/Susan Walsh, File)

Life­time phar­ma ban? ‘Phar­ma Bro’ re­turns with ‘soft­ware’ com­pa­ny for drug dis­cov­ery

Fa­mous for sky­rock­et­ing the price of a life­sav­ing drug and get­ting in­to feuds with any­body and every­body on the in­ter­net and in Con­gress, the “Phar­ma Bro” is back, sort of. In­stead of hik­ing drug prices, he claims he’s low­er­ing the costs for those at­tempt­ing to dis­cov­er drugs.

Mar­tin Shkre­li has co-found­ed a new com­pa­ny, which he claims to be a “Web3 drug dis­cov­ery soft­ware plat­form.”

That is, of course, be­cause Shkre­li re­ceived a life­time ban from the phar­ma­ceu­ti­cal in­dus­try, a bar­ri­er that he has, as his own at­tor­ney, failed to get over­turned. Yet the in­dus­try still fu­els the fo­cus of his on­line pres­ence, with videos of him de­rid­ing the “lack of trans­paren­cy” at Mark Cuban’s phar­ma­cy com­pa­ny — which aims to re­duce costs for pa­tients — along­side oth­er opin­ions and memes.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.